GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Medincell SA (FRA:MEB) » Definitions » Issuance of Stock

Medincell (FRA:MEB) Issuance of Stock : €0.04 Mil (TTM As of Mar. 2024)


View and export this data going back to 2018. Start your Free Trial

What is Medincell Issuance of Stock?

Medincell's Issuance of Stock for the six months ended in Mar. 2024 was €0.04 Mil.

Medincell's Issuance of Stock for the trailing twelve months (TTM) ended in Mar. 2024 was €0.04 Mil.


Medincell Issuance of Stock Historical Data

The historical data trend for Medincell's Issuance of Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Medincell Issuance of Stock Chart

Medincell Annual Data
Trend Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Issuance of Stock
Get a 7-Day Free Trial Premium Member Only 0.04 42.29 0.05 0.81 23.32

Medincell Semi-Annual Data
Mar16 Mar17 Sep17 Mar18 Sep18 Mar19 Sep19 Mar20 Sep20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23 Mar24 Sep24
Issuance of Stock Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - 23.28 0.04 -

Medincell Issuance of Stock Calculation

A company may raise cash from issuing new shares. Issuance of Stock represents the cash inflow from offering common stock, which is the additional capital contribution to the entity during the period.

Issuance of Stock for the trailing twelve months (TTM) ended in Mar. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was €0.04 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Medincell Issuance of Stock Related Terms

Thank you for viewing the detailed overview of Medincell's Issuance of Stock provided by GuruFocus.com. Please click on the following links to see related term pages.


Medincell Business Description

Traded in Other Exchanges
Address
3 rue des Freres Lumiere, Jacou, FRA, 34830
Medincell SA is a technology-based pharmaceutical firm, aims to optimise the efficiency of medical treatments and make them accessible geographically. The company's product portfolio uses BEPO-patented technology to develop controlled, long-acting injectable medical treatments for a number of therapeutic fields. The firm has a single operating segment: ongoing research and development on processes that use biodegradable polymers to enable the controlled and prolonged release of the active principles of drugs into the human body and animals by means of injection.

Medincell Headlines

No Headlines